Healthcare & Life Sciences
HanchorBio
Taiwanwww.hanchorbio.com
HanchorBio is a Healthcare & Life Sciences startup based in Taiwan, most recent round Series C+, 1 tracked investor.
Activeseries-c-plus
series-c-plus
Stage
1
Investors
About HanchorBio
HanchorBio is a company headquartered in Taiwan. Its most recent tracked round is Series C+. Brouky classifies it under Healthcare & Life Sciences. Brouky records 1 investor associated with the company.
HanchorBio develops Fc-Based Designer Biologics (FBDB™) that create ligand traps to block multi-ligand immune interactions; its lead candidate HCB101 is in US Phase 1 clinical trials targeting the SIPRα-CD47 pathway for advanced solid tumors and relapsed/refractory non-Hodgkin lymphoma.
Explore HanchorBio's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.